Baseline Tumor <sup>18</sup>F-FDG Uptake and Modifications After 2 Cycles of Neoadjuvant Chemotherapy Are Prognostic of Outcome in ER+/HER2− Breast Cancer - Concepedia

Concepedia

Publication | Open Access

Baseline Tumor <sup>18</sup>F-FDG Uptake and Modifications After 2 Cycles of Neoadjuvant Chemotherapy Are Prognostic of Outcome in ER+/HER2− Breast Cancer

DOI Full Paper Access

72

Citations

16

References

2015

Year

David Groheux, Alice Sanna, Mohamed Majdoub, Patricia de Crémoux, Sylvie Giacchetti, Luís Teixeira, Marc Espié, Pascal Merlet, Anne de Roquancourt, Dimitris Visvikis,

Journal of Nuclear Medicine

Abstract

Baseline tumor (18)F-FDG uptake and modifications after 2 cycles of NAC are prognostic of outcome in patients with ER+/HER2- breast cancer.

References

	Year	Citations

Page 1